Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S L Braheny

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Muscle & Nerve|July 1, 1985
Endoneurial injection of antisera to myelin antigensR A Hughes, H C Powell, S L Braheny, et al.
The American Journal of Pathology|March 1, 1984
Antigen-specific demyelination and significance of the bystander effect in peripheral nervesH C Powell, S L Braheny, R A Hughes, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 1, 1983
Early changes in experimental allergic neuritisH C Powell, S L Braheny, R R Myers, et al.
Journal of Neuroimmunology|April 1, 1984
Disease activity markers in multiple sclerosis. Another look at suppressor cells defined by monoclonal antibodies OKT4, OKT5, and OKT8G P Rice, D Finney, S L Braheny, et al.
Annals of the New York Academy of Sciences|January 1, 1984
The failure of monoclonal antibody-defined lymphocyte subsets to monitor disease activity in patients with multiple sclerosisG P Rice, J C Sipe, S L Braheny, et al.
Neurology|October 1, 1984
A neurologic rating scale (NRS) for use in multiple sclerosisJ C Sipe, R L Knobler, S L Braheny, et al.
Annals of Neurology|October 1, 1985
Immunological complications in multiple sclerosis patients receiving interferonG P Rice, E L Woelfel, P J Talbot, et al.
Neurology|October 1, 1984
Systemic alpha-interferon therapy of multiple sclerosisR L Knobler, H S Panitch, S L Braheny, et al.
Annals of the New York Academy of Sciences|January 1, 1984
Clinical trial of natural alpha interferon in multiple sclerosisR L Knobler, H S Panitch, S L Braheny, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Muscle & Nerve|July 1, 1985
Endoneurial injection of antisera to myelin antigensR A Hughes, H C Powell, S L Braheny, et al.
The American Journal of Pathology|March 1, 1984
Antigen-specific demyelination and significance of the bystander effect in peripheral nervesH C Powell, S L Braheny, R A Hughes, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 1, 1983
Early changes in experimental allergic neuritisH C Powell, S L Braheny, R R Myers, et al.
Journal of Neuroimmunology|April 1, 1984
Disease activity markers in multiple sclerosis. Another look at suppressor cells defined by monoclonal antibodies OKT4, OKT5, and OKT8G P Rice, D Finney, S L Braheny, et al.
Annals of the New York Academy of Sciences|January 1, 1984
The failure of monoclonal antibody-defined lymphocyte subsets to monitor disease activity in patients with multiple sclerosisG P Rice, J C Sipe, S L Braheny, et al.
Neurology|October 1, 1984
A neurologic rating scale (NRS) for use in multiple sclerosisJ C Sipe, R L Knobler, S L Braheny, et al.
Annals of Neurology|October 1, 1985
Immunological complications in multiple sclerosis patients receiving interferonG P Rice, E L Woelfel, P J Talbot, et al.
Neurology|October 1, 1984
Systemic alpha-interferon therapy of multiple sclerosisR L Knobler, H S Panitch, S L Braheny, et al.
Annals of the New York Academy of Sciences|January 1, 1984
Clinical trial of natural alpha interferon in multiple sclerosisR L Knobler, H S Panitch, S L Braheny, et al.
Pageof 1